Posted by stargazer2 on October 31, 2007, at 8:31:50
In reply to Re: Budeprion (Generic) vs. Wellbutrin, posted by CaveMan on October 30, 2007, at 18:15:18
This issue has been brought to the FDA's attention becasue of so many complaints. They are looking into it. Many people have said it is not working as well as Buproprion did.
This happened with Nardil as well but since there are not as many people on Nardil, so I think it has fallen on deaf ears.
The pharmaceutical companies have gottn away from testing the generic drugs since the generics supposedly contain the same active ingredients as the brand name. But what is not the same are some of the 'non-active" ingredients which affect thing like the absorption time, etc.
It's not happening just with psych meds either. People on BP meds are finding their BP is not being controlled with some of the generics.
It's bad enough when it happens to one generic but many brands have multiple generics.
How many people out there are taking generics and suffering from them and don't even know it?
It sounds like a major blunder on the part of the FDA....They don't have enough staff as it is to test all the new 'brand' name meds, let alone,all of the generic forms of the brand.
Wellbutrin is the brand, Bupropprion is the generic, so what is Budeprion, the generic of the generic? It's mind boggling and the impact of all of this is more patients who have been stabalized being destabalized. A real health care crisis if you ask me.